President Trump Signs Executive Order Encouraging Psychedelic Research
The psychedelic executive order research marks a significant shift in federal policy encouraging clinical trials on psychedelic drugs. This change aims to reduce regulatory barriers and accelerate research on treatment-resistant psychiatric conditions.…
Trump Signs Order To Accelerate Legal Access To Psychedelic Therapies For Mental Health
The recent executive order aims to accelerate psychedelic-assisted therapies mental health access, potentially transforming treatment for resistant depression and PTSD. This policy shift could open new pathways for patients who have not responded to…
Trump Plans Psychedelic Executive Order (Newsletter: April 17, 2026)
The 2026 psychedelic drug policy developments could reshape access to psilocybin and MDMA treatments currently in FDA trials. These changes matter clinically for patients with PTSD and depression. Clinicians should monitor these developments closely for…
Hawaii Lawmakers Approve Bill To Create Psychedelics Task Force
Hawaii lawmakers have approved a bill to create a psychedelics task force study focused on psilocybin and MDMA. This task force will examine therapeutic applications and regulatory considerations. The study reflects growing interest in psychedelic…
Psilocybin mushrooms are going mainstream, but scientific research and regulation lag behind
Psilocybin mushrooms regulation is lagging behind their mainstream adoption, creating clinical risks. Scientific research on psilocybin remains limited, complicating safe patient care. Clinicians must navigate drug interactions and screening to ensure…
Volunteers Prepare to Bring Mental Health Awareness to Sask. Agriculture and Rodeo Circuit
Agricultural workers mental health is a growing concern due to unique stressors like financial instability and social isolation. Volunteers in Saskatchewan are preparing to raise awareness through rodeo circuit outreach. This initiative aims to improve…
Cannabis Provides Help For Patients With Chronic Pain, Anxiety, and Depression
Cannabis chronic pain anxiety depression evidence highlights its potential benefits for patients. Clinical trials support cannabis use for neuropathic pain, while anxiety and depression require cautious approaches. Understanding this evidence helps guide…
Mental Health Problems More Likely for Teen Cannabis Users
Adolescent cannabis mental health studies show increased psychiatric risks for teen cannabis users. These studies highlight the vulnerability of the developing brain to cannabis exposure. Clinicians should screen for cannabis use alongside mental health…
Why Cannabis May Not Relieve Anxiety or Depression
Emerging research on cannabis efficacy mood disorders shows mixed results for anxiety and depression relief. Many patients use cannabis products hoping for symptom improvement, but clinical evidence remains limited. Clinicians must address these evidence…
A New Take on the Antidepressants vs Psychedelics Efficacy Debate – Drug Science
This article explores psychedelic therapies for depression, focusing on their efficacy compared to traditional antidepressants. It highlights the clinical complexity in comparing these treatments for patients with treatment-resistant depression.…